Welcome to SEQ Services, your trusted partner for expert regulatory support in the realm of Biosimilars. We specialize in providing comprehensive services that ensure biosimilar products meet the highest standards of quality, safety, and efficacy.
Biosimilar Defined: SEQ provides expertise in navigating the regulatory landscape for new biological products developed to be similar to existing licensed biological products.
Challenges Beyond Generic Medicines: Recognizing the unique challenges of biosimilar, SEQ adopts a distinct approach that goes beyond small-molecule generic medicines.
EU Pathway for Biosimilar Approval: Since 2003, SEQ has been a reliable partner, offering regulatory guidance in alignment with the EU pathway for approving biosimilar medicines.
Thorough Evaluation: SEQ’s distinct approach involves thorough testing and evaluation to ensure biosimilar align with reference medicines, highlighting any significant differences.
Life Cycle Management: SEQ provides comprehensive support throughout the life cycle of biosimilar, adapting to evolving regulatory requirements.
Contact Us: For tailored solutions to your biosimilar regulatory needs, reach out to SEQ at enquiries@nerin.co.im. Explore how SEQ can be your partner in navigating the unique challenges of biosimilar development and compliance.
